Lead Sponsor

Eastern Switzerland University of Applied Sciences

Collaborators

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
University of Zurich

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•aged ≥ 18 years
•stable condition \> 3 weeks (e.g. no exacerbations)
•resting SpO2 ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/or below 90% during a 6-minute walk test (6MWT)
•informed consent as documented by signature.

•Severe daytime resting hypoxemia (SpO2 \< 88%)
•long-term oxygen therapy
•unstable condition requiring adaptation of pharmacologic and other treatment modalities or requirement of intensive care or relevant severe concomitant disease
•inability to follow the procedures of the study, e.g. due to language problems psychological disorders, neurological or orthopedic problems with walking disability or inability to ride a bicycle
•women who are pregnant or breast feeding
•enrolment in another clinical trial with active treatment.

Related studies

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)

NCT07383896 · Asthma, COPD

NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more

NCT07518472 · Pulmonary Disease, Chronic Obstructive (COPD)

Oxygen Therapy During Exercise Training in Inpatient Rehabilitation in Chronic Lung Disease- Does it Matter?